Downregulation of Hus1 by antisense oligonucleotides enhances the sensitivity of human lung carcinoma cells to cisplatin

Bernd Kinzel(Novartis (Switzerland)), Dalia Cohen(Regulus Therapeutics (United States)), Jonathan Hall(Novartis (Switzerland)), François Natt(Novartis (Switzerland)), Jan Weiler(Novartis (Switzerland))
Cancer
March 15, 2002
Cited by 21


Related Papers